Cargando…
CCR6 as a Potential Target for Therapeutic Antibodies for the Treatment of Inflammatory Diseases
The CC chemokine receptor 6 (CCR6) is a G protein-coupled receptor (GPCR) involved in a wide range of biological processes. When CCR6 binds to its sole ligand CCL20, a signaling network is produced. This pathway is implicated in mechanisms related to many diseases, such as cancer, psoriasis, multipl...
Autores principales: | Gómez-Melero, Sara, Caballero-Villarraso, Javier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10123731/ https://www.ncbi.nlm.nih.gov/pubmed/37092451 http://dx.doi.org/10.3390/antib12020030 |
Ejemplares similares
-
Development of a High-Throughput Calcium Mobilization Assay for CCR6 Receptor Coupled to Hydrolase Activity Readout
por: Gómez-Melero, Sara, et al.
Publicado: (2022) -
CCR9 antagonism: potential in the treatment of Inflammatory Bowel Disease
por: Wendt, Emily, et al.
Publicado: (2015) -
Modulation of the CCR6-CCL20 Axis: A Potential Therapeutic Target in Inflammation and Cancer
por: Ranasinghe, Ranmali, et al.
Publicado: (2018) -
CCR9 in cancer: oncogenic role and therapeutic targeting
por: Tu, Zhenbo, et al.
Publicado: (2016) -
CCR4 as a Therapeutic Target for Cancer Immunotherapy
por: Yoshie, Osamu
Publicado: (2021)